Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)

Esteban Jódar; William Polonsky; Rosangela Rea; Mark L Warren; Tina Vilsbøll; Jonas Håkan-Bloch; Hrvoje Vrazic; Søren Østergaard Lindberg; S.C. Bain

doi:10.1007/s12529-018-9740-1

Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)

Esteban Jódar, William Polonsky, Rosangela Rea, Mark L Warren, Tina Vilsbøll, Jonas Håkan-Bloch, Hrvoje Vrazic, Søren Østergaard Lindberg, S.C. Bain

Steno Diabetes Center Copenhagen

Originalsprog	Engelsk
Artikelnummer	761
Tidsskrift	Diabetologia
Vol/bind	61
Udgave nummer	Suppl 1
Sider (fra-til)	S372-S373
Antal sider	1
ISSN	0012-186X
DOI	https://doi.org/10.1007/s12529-018-9740-1
Status	Udgivet - 1 okt. 2018
Begivenhed	54th EASD Annual Meeting: EASD 2018 - Berlin, Tyskland Varighed: 1 okt. 2018 → 5 okt. 2018 https://www.easd.org/programme-2018.html

Konference

Konference	54th EASD Annual Meeting
Land/Område	Tyskland
By	Berlin
Periode	01/10/2018 → 05/10/2018
Internetadresse	https://www.easd.org/programme-2018.html

Adgang til dokumentet

10.1007/s12529-018-9740-1

Citationsformater

Jódar, E., Polonsky, W., Rea, R., Warren, M. L., Vilsbøll, T., Håkan-Bloch, J., Vrazic, H., Lindberg, S. Ø., & Bain, S. C. (2018). Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6). Diabetologia, 61(Suppl 1), S372-S373. Artikel 761. https://doi.org/10.1007/s12529-018-9740-1

Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6). / Jódar, Esteban; Polonsky, William; Rea, Rosangela et al.
I: Diabetologia, Bind 61, Nr. Suppl 1, 761, 01.10.2018, s. S372-S373.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

@article{c466a960af5b41fb94f64f5e1e3ce1ed,

title = "Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)",

author = "Esteban J{\'o}dar and William Polonsky and Rosangela Rea and Warren, {Mark L} and Tina Vilsb{\o}ll and Jonas H{\aa}kan-Bloch and Hrvoje Vrazic and Lindberg, {S{\o}ren {\O}stergaard} and S.C. Bain",

year = "2018",

month = oct,

day = "1",

doi = "10.1007/s12529-018-9740-1",

language = "English",

volume = "61",

pages = "S372--S373",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "Suppl 1",

note = "54th EASD Annual Meeting : EASD 2018 ; Conference date: 01-10-2018 Through 05-10-2018",

url = "https://www.easd.org/programme-2018.html",

}

TY - ABST

T1 - Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)

AU - Jódar, Esteban

AU - Polonsky, William

AU - Rea, Rosangela

AU - Warren, Mark L

AU - Vilsbøll, Tina

AU - Håkan-Bloch, Jonas

AU - Vrazic, Hrvoje

AU - Lindberg, Søren Østergaard

AU - Bain, S.C.

PY - 2018/10/1

Y1 - 2018/10/1

U2 - 10.1007/s12529-018-9740-1

DO - 10.1007/s12529-018-9740-1

M3 - Conference abstract in journal

C2 - 30109476

SN - 0012-186X

VL - 61

SP - S372-S373

JO - Diabetologia

JF - Diabetologia

IS - Suppl 1

M1 - 761

T2 - 54th EASD Annual Meeting

Y2 - 1 October 2018 through 5 October 2018

ER -